Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Beijing Friendship Hospital, Capital Medical University, Beijing

Jilin Cancer Hospital, Changchun

Fudan University Shanghai Cancer Center, Shanghai

Shanghai East Hospital, Shanghai

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Henan Cancer Hospital, Zhengzhou

Sun Yat Sen University Cancer Center, Guangzhou

West China Hospital, Sichuan University, Chengdu